raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:100994

Autosomal dominant spastic paraplegia type 13

Synonyms: SPG13

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adolescent, Adult
Status
active

A rare, pure or complex form of hereditary spastic paraplegia characterized by progressive spastic paraplegia with pyramidal signs in the upper and lower limbs, and decreased vibration sense.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal dominant spastic paraplegia type 13SPG13
frParaplégie spastique autosomique dominante type 13= en
deSpastische Paraplegie, autosomal-dominante, Typ 13= en
esParaplejía espástica autosómica dominante tipo 13= en
itParaplegia spastica autosomica dominante tipo 13= en
nlAutosomaal dominante spastische paraplegie type 13= en
ptParaplegia espástica autossómica dominante tipo 13= en
plAutosomalna dominująca paraplegia spastyczna typu 13= en
csAutozomálně dominantní spastická paraplegie, typ 13= en
ukАутосомно-домінантна спастична параплегія, тип 13= en
zh常染色体显性遗传痉挛性截瘫13型= en
trOtozomal dominant spastik parapleji tip 13= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM605280Evalidated
ICD-10G11.4NTBTattributedvalidated
ICD-118B44.00NTBTindexvalidated
MONDO0011532Evalidated
MeSHC537485Evalidated
UMLSC1854467Evalidated
GARD9616Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
HSPD1Disease-causing germline mutation(s) inAssessedHGNC:5261ENSG000001443811181902q33.1heat shock protein family D (Hsp60) member 11189812[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families10 casesWorldwideCase(s)Validated10677329[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_10677329[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2018-02-26
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001258Spastic paraplegia
HP:0002839Urinary bladder sphincter dysfunction
Frequent (79-30%)
HP:0007256Abnormal pyramidal sign
HP:0003487Babinski sign
HP:0001347Hyperreflexia
HP:0007350Hyperreflexia in upper limbs
HP:0002166Impaired vibration sensation in the lower limbs
HP:0007340Lower limb muscle weakness
HP:0002061Lower limb spasticity
HP:0002064Spastic gait
HP:0000020Urinary incontinence
Occasional (29-5%)
HP:0001761Pes cavus
HP:0002650Scoliosis
HP:0000012Urinary urgency
Very rare (<4-1%)
HP:0000365Hearing impairment
HP:0000510Rod-cone dystrophy

Run the differential on the 2 obligate / very frequent terms

Annotation source: 10677329[PMID]_11898127[PMID]_18853458[PMID]

7

Sources for this card